EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta‐Analysis With Trial Sequential Analysis

Ansel Shao Pin Tang, Jingxuan Quek, Farisah Sulaimi, Ben Sim, Timothy Ong Sheng Kai, Elna Yihui Soon, Celeste Natasha Goh, Jolene Li Jun Hsu, Charrise Kai Ling Lee, Sheena Kar Shuan Chong, Ashita Ashish Sule, Ryan Ruiyang Ling und 2 weitere

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70322 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Ansel Shao Pin Tang und 13 weiteren Autor:innen. Beteiligte Einrichtung: NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Probiotics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent years have seen greater interest, and hence, many trials published on the topic of probiotics as a treatment for irritable bowel syndrome (IBS). Given the anticipated “multiplicity problem” and inadequacy of traditional meta‐analysis, this study aims to evaluate the efficacy of probiotics in alleviating symptoms of IBS and improve quality of life through a trial sequential analysis (TSA).

Methods

Medline, Embase, Web of Science, and Cochrane were screened for randomized controlled trials (RCTs) comparing probiotics to placebo in adult patients with IBS. Primary outcomes included changes in IBS Symptom Severity Score (IBS‐SSS) and IBS Quality of Life (IBS‐QOL) scores. A traditional pairwise meta‐analysis conducted in DerSimonian and Laird was conducted, with subsequent TSA. Study quality was graded according to risk‐of‐bias 2 (ROB‐2), and certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).

Results

A total of 40 studies were included. Overall, probiotics demonstrated significant improvements in IBS‐SSS (MD: 33.42, 95% confidence interval [CI]: −55.96 to −10.88, p < 0.01) but nonsignificant improvements in IBS‐QOL (MD: 1.79, 95% CI: −3.00–6.57, p = 0.46). TSA conducted on IBS‐SSS demonstrated current evidence has not reached the required information size. Cumulative Z‐curve demonstrated no evidence of futility, benefit, or detrimental effect. Evaluation by ROB‐2 indicates the majority of studies were of low risk of bias, while GRADE evaluation of existing evidence demonstrated low certainty of evidence, mainly attributed to inconsistency.

Discussion

TSA findings recommend further high‐powered trials. GRADE evaluation emphasizes the importance of standardization in future trials and further efforts to identify sources of heterogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeProbioticsHumansQuality of LifeTreatment OutcomeRandomized Controlled Trials as TopicSeverity of Illness IndexAdult

Stichwörter der Autor:innen

IBSefficacyirritable bowel syndromemeta‐analysissystematic reviewtrial sequential analysis

Autor:innen und Institutionen

  • NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Wallace Wurth, University of New South Wales, Sydney, New South Wales, Australia.
  • The School of Medicine at the University of Dublin, Trinity College of Dublin, Dublin, Ireland.
  • Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Division of Gastroenterology & Hepatology, University Medicine Cluster, National University Hospital, Singapore, Singapore.
  • Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.

ORCID-Profile: Qin Xiang Ng

Zitieren

APA

Tang, A. S. P., Quek, J., Sulaimi, F., Sim, B., Kai, T. O. S., Soon, E. Y., Goh, C. N., Hsu, J. L. J., Lee, C. K. L., Chong, S. K. S., Sule, A. A., Ling, R. R., Siah, K. T. H., & Ng, Q. X. (2026). Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta‐Analysis With Trial Sequential Analysis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70322

Vancouver

Tang ASP, Quek J, Sulaimi F, Sim B, Kai TOS, Soon EY, et al. Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta‐Analysis With Trial Sequential Analysis. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70322

BibTeX
@article{Tang2026,
  author = {Tang, Ansel Shao Pin and Quek, Jingxuan and Sulaimi, Farisah and Sim, Ben and Kai, Timothy Ong Sheng and Soon, Elna Yihui and Goh, Celeste Natasha and Hsu, Jolene Li Jun and Lee, Charrise Kai Ling and Chong, Sheena Kar Shuan and Sule, Ashita Ashish and Ling, Ryan Ruiyang and Siah, Kewin Tien Ho and Ng, Qin Xiang},
  title = {Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta‐Analysis With Trial Sequential Analysis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70322}
}
Kostenlos starten →